-
1
-
-
0035032662
-
Gene therapy restores vision in a canine model of childhood blindness
-
Acland, G.M., Aguirre, G.D., Ray, J., Zhang, Q., Aleman, T.S., Cideciyan, A.V., Pearce-Kelling, S.E., Anand, V., Zeng, Y., Maguire, A.M., Jacobson, S.G., Hauswirth, W.W., and Bennett, J., 2001, Gene therapy restores vision in a canine model of childhood blindness, Nat. Genet. 28:92-95.
-
(2001)
Nat. Genet.
, vol.28
, pp. 92-95
-
-
Acland, G.M.1
Aguirre, G.D.2
Ray, J.3
Zhang, Q.4
Aleman, T.S.5
Cideciyan, A.V.6
Pearce-Kelling, S.E.7
Anand, V.8
Zeng, Y.9
Maguire, A.M.10
Jacobson, S.G.11
Hauswirth, W.W.12
Bennett, J.13
-
2
-
-
0034200932
-
Gene therapy for ocular disease
-
Bennett, J. and Maguire, A.M., 2000, Gene therapy for ocular disease, Mol. Ther. 1:501-505.
-
(2000)
Mol. Ther.
, vol.1
, pp. 501-505
-
-
Bennett, J.1
Maguire, A.M.2
-
3
-
-
0035987409
-
Gene therapy for retinal and choroidal diseases
-
Campochiaro, P.A., 2002, Gene therapy for retinal and choroidal diseases, Expert. Opin. Biol. Ther 2:537-544.
-
(2002)
Expert. Opin. Biol. Ther
, vol.2
, pp. 537-544
-
-
Campochiaro, P.A.1
-
4
-
-
0030924589
-
Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina
-
Grant, C.A., Ponnazhagan, S., Wang, X.S., Srivastava, A., and Li, T., 1997, Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina, Curr. Eye Res. 16: 949-956.
-
(1997)
Curr. Eye Res.
, vol.16
, pp. 949-956
-
-
Grant, C.A.1
Ponnazhagan, S.2
Wang, X.S.3
Srivastava, A.4
Li, T.5
-
5
-
-
0033862099
-
Early-onset severe rod-cone dystrophy in young children with RPE65 mutations
-
Lorenz, B., Gyurus, P., Preising, M., Bremser, D., Gu, S., Andrassi, M., Gerth, C., and Gal, A., 2000, Early-onset severe rod-cone dystrophy in young children with RPE65 mutations, Invest. Ophthalmol. Vis. Sci. 41:2735-2742.
-
(2000)
Invest. Ophthalmol. Vis. Sci.
, vol.41
, pp. 2735-2742
-
-
Lorenz, B.1
Gyurus, P.2
Preising, M.3
Bremser, D.4
Gu, S.5
Andrassi, M.6
Gerth, C.7
Gal, A.8
-
6
-
-
0023706589
-
Chronic administration of a selective dopamine D-2 agonist:factors determining behavioral tolerance and sensitization
-
Martin-Iverson, M.T., Stahl, S.M., and Iversen, S.D., 1988, Chronic administration of a selective dopamine D-2 agonist:factors determining behavioral tolerance and sensitization, Psychopharmacology (Berl) 95:534-539.
-
(1988)
Psychopharmacology (Berl)
, vol.95
, pp. 534-539
-
-
Martin-Iverson, M.T.1
Stahl, S.M.2
Iversen, S.D.3
-
7
-
-
0031252434
-
Mutations in RPE65 cause Leber's congenital amaurosis
-
Marlhens, F., Bareil, C., Griffoin, J.M., Zrenner, E., Amalric, P., Eliaou, C., Liu, S.Y., Harris, E., Redmond, T.M., Arnaud, B., Claustres, M., and Hamel, C.P., 1997, Mutations in RPE65 cause Leber's congenital amaurosis, Nat. Genet. 17:139-141.
-
(1997)
Nat. Genet.
, vol.17
, pp. 139-141
-
-
Marlhens, F.1
Bareil, C.2
Griffoin, J.M.3
Zrenner, E.4
Amalric, P.5
Eliaou, C.6
Liu, S.Y.7
Harris, E.8
Redmond, T.M.9
Arnaud, B.10
Claustres, M.11
Hamel, C.P.12
-
8
-
-
0037379354
-
Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog
-
In Press
-
Narfstrom, K., Katz, M.L., Bragadottir, R., Seeliger, M., Boulanger, A., Redmond, T.M, Caro, L., Lai, C-M., Rakoczy, E., 2002, Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog, Invest. Opthalmol. Vis. Sci. (In Press).
-
(2002)
Invest. Opthalmol. Vis. Sci.
-
-
Narfstrom, K.1
Katz, M.L.2
Bragadottir, R.3
Seeliger, M.4
Boulanger, A.5
Redmond, T.M.6
Caro, L.7
Lai, C.-M.8
Rakoczy, E.9
-
9
-
-
0034094703
-
Genetic analysis of RPE65: From human disease to mouse model
-
Redmond, T.M. and Hamel, C.P., 2000, Genetic analysis of RPE65: from human disease to mouse model, Methods Enzymol. 316:705-724.
-
(2000)
Methods Enzymol.
, vol.316
, pp. 705-724
-
-
Redmond, T.M.1
Hamel, C.P.2
-
10
-
-
17344366357
-
Rpe65 is necessary for production of 11-cis-vitamin a in the retinal visual cycle
-
Redmond, T.M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.X., Crouch, R.K., and Pfeifer, K., 1998, Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle, Nat. Genet. 20:344-351.
-
(1998)
Nat. Genet.
, vol.20
, pp. 344-351
-
-
Redmond, T.M.1
Yu, S.2
Lee, E.3
Bok, D.4
Hamasaki, D.5
Chen, N.6
Goletz, P.7
Ma, J.X.8
Crouch, R.K.9
Pfeifer, K.10
-
11
-
-
0029242185
-
AAV as a viral vector for human gene therapy. Generation of recombinant virus
-
Rolling, F. and Samulski, R.J., 1995, AAV as a viral vector for human gene therapy. Generation of recombinant virus, Mol. Biotechnol. 3:9-15.
-
(1995)
Mol. Biotechnol.
, vol.3
, pp. 9-15
-
-
Rolling, F.1
Samulski, R.J.2
-
12
-
-
0033106311
-
Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography
-
Rolling, F., Shen, W.Y., Tabarias, H., Constable, I., Kanagasingam, Y., Barry, C.J., and Rakoczy, P.E., 1999, Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography, Hum. Gene Ther. 10: 641-648.
-
(1999)
Hum. Gene Ther.
, vol.10
, pp. 641-648
-
-
Rolling, F.1
Shen, W.Y.2
Tabarias, H.3
Constable, I.4
Kanagasingam, Y.5
Barry, C.J.6
Rakoczy, P.E.7
-
13
-
-
0002463912
-
Retinoids in Photosensetive Systems
-
edited by Sporn, M.B., Roberts, A.B., and Goodman, D.S. (Raven Press, New York, 1994)
-
Saari, J.C., Retinoids in Photosensetive Systems in: The Retinoids, edited by Sporn, M.B., Roberts, A.B., and Goodman, D.S. (Raven Press, New York, 1994), pp. 351-384.
-
The Retinoids
, pp. 351-384
-
-
Saari, J.C.1
-
14
-
-
17944379443
-
New views on RPE65 deficiency: The rod system is the source of vision in a mouse model of Leber congenital amaurosis
-
Seeliger, M.W., Grimm, C., Stahlberg, F., Friedburg, C., Jaissle, G., Zrenner, E., Guo, H., Reme, C.E., Humphries, P., Hofmann, F., Biel, M., Fariss, R.N., Redmond, T.M., and Wenzel, A., 2001, New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis, Nat. Genet. 29:70-74.
-
(2001)
Nat. Genet.
, vol.29
, pp. 70-74
-
-
Seeliger, M.W.1
Grimm, C.2
Stahlberg, F.3
Friedburg, C.4
Jaissle, G.5
Zrenner, E.6
Guo, H.7
Reme, C.E.8
Humphries, P.9
Hofmann, F.10
Biel, M.11
Fariss, R.N.12
Redmond, T.M.13
Wenzel, A.14
-
15
-
-
0033022953
-
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
-
Zolotukhin, S., Byrne, B.J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R.J., and Muzyczka, N., 1999, Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield, Gene Ther. 6:973-985.
-
(1999)
Gene Ther.
, vol.6
, pp. 973-985
-
-
Zolotukhin, S.1
Byrne, B.J.2
Mason, E.3
Zolotukhin, I.4
Potter, M.5
Chesnut, K.6
Summerford, C.7
Samulski, R.J.8
Muzyczka, N.9
|